BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 26, 2004
View Archived Issues
Aranesp, Enbrel, Neulasta Sales Drive Amgen To Beat Estimates
Amgen Inc. turned in second-quarter adjusted earnings per share of 62 cents, topping consensus estimates and surging 27 percent higher than a year ago. (BioWorld Today)
Read More
Gene Logic Acquires Discovery Program, Team From Millennium
Read More
Specialty Pharma Firm Auxilium Raises $41.25M In Initial Offering
Read More
Santarus Gets $57M In Follow-On Following Approval Of Rapinex
Read More
Hudson Health Gains Listing Via Reverse Merger, Raises $8M
Read More
Tapestry Calls On Supratek To Help Develop New Formulations
Read More
Other News To Note
Read More